Teva- Pharmaceutical Industries Ltd. - ADR

TEVA

Market Cap$15.55B

Close$

Compare Teva- Pharmaceutical Industries Ltd. - ADR

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Teva- Pharmaceutical Industries Ltd. - ADR	-27.9	0%	-7%	0.9	2.6
Market Avg	59.7	1.27%	30%	-	0.9
Healthcare Avg	64.5	1.29%	15%	7.1	0.8

$19.00

Target Price by Analysts

44.2% upsideTeva- Pharmaceutical Industries Ltd. - ADR Target Price Details

$-3.88

Current Fair Value

129.4% downside

Overvalued by 129.4% based on the discounted cash flow analysis.

Share Statistics

Market cap	$15.55 Billion
Enterprise Value	$32.16 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-0.5
Beta	0.56
Outstanding Shares	1,120,992,397
Avg 30 Day Volume	7,789,042

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-27.86
PEG	20.6
Price to Sales	0.94
Price to Book Ratio	2.2
Enterprise Value to Revenue	2.03
Enterprise Value to EBIT	10.06
Enterprise Value to Net Income	-58
Total Debt to Enterprise	0.62
Debt to Equity	2.64

Revenue Sources

No data

ESG Score

No data

About Teva- Pharmaceutical Industries Ltd.

CEO: Kaare Schultz